These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 29570947

  • 1. Halogenated Bis(methoxybenzylidene)-4-piperidone Curcuminoids with Improved Anticancer Activity.
    Schmitt F, Subramaniam D, Anant S, Padhye S, Begemann G, Schobert R, Biersack B.
    ChemMedChem; 2018 Jun 06; 13(11):1115-1123. PubMed ID: 29570947
    [Abstract] [Full Text] [Related]

  • 2. Fluoro and pentafluorothio analogs of the antitumoral curcuminoid EF24 with superior antiangiogenic and vascular-disruptive effects.
    Schmitt F, Gold M, Begemann G, Andronache I, Biersack B, Schobert R.
    Bioorg Med Chem; 2017 Sep 01; 25(17):4894-4903. PubMed ID: 28774574
    [Abstract] [Full Text] [Related]

  • 3. Antiproliferative Effect of a Novel 4,4'-Disulfonyldiarylidenyl Piperidone in Human Colon Cancer Cells.
    Prabhat AM, Kuppusamy ML, Bognár B, Kálai T, Hideg K, Kuppusamy P.
    Cell Biochem Biophys; 2019 Mar 01; 77(1):61-67. PubMed ID: 30552554
    [Abstract] [Full Text] [Related]

  • 4. Novel Curcumin Inspired Antineoplastic 1-Sulfonyl-4-Piperidones: Design, Synthesis and Molecular Modeling Studies.
    Fawzy NG, Panda SS, Fayad W, El-Manawaty MA, Srour AM, Girgis AS.
    Anticancer Agents Med Chem; 2019 Mar 01; 19(8):1069-1078. PubMed ID: 30961509
    [Abstract] [Full Text] [Related]

  • 5. Anticancer activity of an imageable curcuminoid 1-[2-aminoethyl-(6-hydrazinopyridine-3-carbamidyl)-3,5-bis-(2-fluorobenzylidene)-4-piperidone (EFAH).
    Lagisetty P, Subramaniam D, Sahoo K, Anant S, Awasthi V.
    Chem Biol Drug Des; 2012 Feb 01; 79(2):194-201. PubMed ID: 22107757
    [Abstract] [Full Text] [Related]

  • 6. Biological Effects of EF24, a Curcumin Derivative, Alone or Combined with Mitotane in Adrenocortical Tumor Cell Lines.
    Bertazza L, Barollo S, Mari ME, Faccio I, Zorzan M, Redaelli M, Rubin B, Armanini D, Mian C, Pezzani R.
    Molecules; 2019 Jun 12; 24(12):. PubMed ID: 31212829
    [Abstract] [Full Text] [Related]

  • 7. Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells.
    He G, Feng C, Vinothkumar R, Chen W, Dai X, Chen X, Ye Q, Qiu C, Zhou H, Wang Y, Liang G, Xie Y, Wu W.
    Cancer Chemother Pharmacol; 2016 Dec 12; 78(6):1151-1161. PubMed ID: 27787644
    [Abstract] [Full Text] [Related]

  • 8. Antibacterial activity of synthetic curcumin derivatives: 3,5-bis(benzylidene)-4-piperidone (EF24) and EF24-dimer linked via diethylenetriaminepentacetic acid (EF2DTPA).
    Vilekar P, King C, Lagisetty P, Awasthi V, Awasthi S.
    Appl Biochem Biotechnol; 2014 Apr 12; 172(7):3363-73. PubMed ID: 24532443
    [Abstract] [Full Text] [Related]

  • 9. Novel 3,5-bis(arylidene)-4-piperidone dimers: potent cytotoxins against colon cancer cells.
    Das S, Das U, Michel D, Gorecki DK, Dimmock JR.
    Eur J Med Chem; 2013 Jun 12; 64():321-8. PubMed ID: 23644215
    [Abstract] [Full Text] [Related]

  • 10. Novel dissymmetric 3,5-bis(arylidene)-4-piperidones as potential antitumor agents with biological evaluation in vitro and in vivo.
    Li N, Xin WY, Yao BR, Wang CH, Cong W, Zhao F, Li HJ, Hou Y, Meng QG, Hou GG.
    Eur J Med Chem; 2018 Mar 10; 147():21-33. PubMed ID: 29421568
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, characterization and ROS-mediated antitumor effects of palladium(II) complexes of curcuminoids.
    Li Y, Gu Z, Zhang C, Li S, Zhang L, Zhou G, Wang S, Zhang J.
    Eur J Med Chem; 2018 Jan 20; 144():662-671. PubMed ID: 29289889
    [Abstract] [Full Text] [Related]

  • 12. A New Pentafluorothio-Substituted Curcuminoid with Superior Antitumor Activity.
    Linder B, Köhler LHF, Reisbeck L, Menger D, Subramaniam D, Herold-Mende C, Anant S, Schobert R, Biersack B, Kögel D.
    Biomolecules; 2021 Jun 25; 11(7):. PubMed ID: 34202286
    [Abstract] [Full Text] [Related]

  • 13. Anticancer potential of novel curcumin analogs towards castrate-resistant prostate cancer.
    Chen S, Nimick M, Cridge AG, Hawkins BC, Rosengren RJ.
    Int J Oncol; 2018 Feb 25; 52(2):579-588. PubMed ID: 29207190
    [Abstract] [Full Text] [Related]

  • 14. Anti-Lung Cancer Activity of the Curcumin Analog JZ534 In Vitro.
    Wu J, Cai Z, Wei X, Chen M, Ying S, Shi L, Xu RA, He F, Liang G, Zhang X.
    Biomed Res Int; 2015 Feb 25; 2015():504529. PubMed ID: 25977922
    [Abstract] [Full Text] [Related]

  • 15. New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo.
    Hsieh MT, Chang LC, Hung HY, Lin HY, Shih MH, Tsai CH, Kuo SC, Lee KH.
    Eur J Med Chem; 2017 May 05; 131():141-151. PubMed ID: 28319780
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of N-substituted 3,5-bis(arylidene)-4-piperidones with high antitumor and antioxidant activity.
    Kálai T, Kuppusamy ML, Balog M, Selvendiran K, Rivera BK, Kuppusamy P, Hideg K.
    J Med Chem; 2011 Aug 11; 54(15):5414-21. PubMed ID: 21702507
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and bioevaluation of novel N-substituted-3,5-bis(arylidene)-4-piperidone derivatives as cytotoxic and antitumor agents with fluorescent properties.
    Sun J, Zhang S, Yu C, Hou G, Zhang X, Li K, Zhao F.
    Chem Biol Drug Des; 2014 Apr 11; 83(4):392-400. PubMed ID: 24148151
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, antitumor activity evaluation of some new N-aroyl-α,β-unsaturated piperidones with fluorescence.
    Sun J, Wang S, Li H, Jiang W, Hou G, Zhao F, Cong W.
    J Enzyme Inhib Med Chem; 2016 Apr 11; 31(3):495-502. PubMed ID: 26382011
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential IκB kinase β inhibitors for the treatment of pancreatic cancer.
    Xie X, Tu J, You H, Hu B.
    Drug Des Devel Ther; 2017 Apr 11; 11():1439-1451. PubMed ID: 28553074
    [Abstract] [Full Text] [Related]

  • 20. The aryl hydrocarbon receptor as an antitumor target of synthetic curcuminoids in colorectal cancer.
    Megna BW, Carney PR, Depke MG, Nukaya M, McNally J, Larsen L, Rosengren RJ, Kennedy GD.
    J Surg Res; 2017 Jun 01; 213():16-24. PubMed ID: 28601309
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.